Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
3.12M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
100
-
Shares change
-
-149K
-
Total reported value, excl. options
-
$1K
-
Value change
-
-$140K
-
Number of buys
-
1
-
Number of sells
-
-5
-
Price
-
$10.00
Significant Holders of Passage BIO, Inc. - COMMON STOCK (PASG) as of Q3 2023
10 filings reported holding PASG - Passage BIO, Inc. - COMMON STOCK as of Q3 2023.
Passage BIO, Inc. - COMMON STOCK (PASG) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 100 shares
of 3.12M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include Erste Asset Management GmbH (2.36M shares), CITADEL ADVISORS LLC (103K shares), Federation des caisses Desjardins du Quebec (8.01K shares), TSFG, LLC (100 shares), Clearstead Advisors, LLC (0 shares), TWO SIGMA SECURITIES, LLC (0 shares), CORNERCAP INVESTMENT COUNSEL INC (0 shares), Annandale Capital, LLC (0 shares), DEUTSCHE BANK AG\ (0 shares), and CITADEL ADVISORS LLC (6.6K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.